Afluria® Quadrivalent
Influenza vaccine quadrivalent (split virion, inactivated)
Product Details
WHO Product ID
FVP-P-350
Status
Prequalified
Date of prequalification
Vaccine type
Influenza vaccine quadrivalent (split virion, inactivated)
Abbreviated Name
IIV4
Commercial Name
Afluria® Quadrivalent
PQ Holder
Australia
NRA of record
US Food and Drug Administration- Office of Vaccine Research and Review (US FDA)
Product description
Pharmaceutical Form
Liquid: Ready to use
Presentation
Vial
Number of doses
10
Route of administration
Intramuscular
Vaccine Vial Monitor
Type 2
Shelf-life
12 months
Storage temperature
2 - 8°C
Diluent
N/A
Preservative
Thiomersal
Preservative concentration
0.01 % w/v
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be used in subsequent immunization sessions (up to 28 days) if the conditions outlined in the WHO Policy Statement are met.
Remarks
Pallet shipper contains 119 shipping boxes (9520 vials/ 95200 doses of 0.5 mL or 190400 of 0.25 mL)
Product Packaging
Secondary Container
Shipping Container
Component Packed
Active (Vaccine)
Total doses
1
Description
Carton of 1 multidose vial (10 doses) [Dimensions: 3.8 x 6.0 x 3.1 cm]
Dimensions
3.8 x 6.0 x 3.1 cm
Cold Chain Volume (cm³/dose)
7.07